Rapid Micro Biosystems (RPID) Net Cash Flow (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Net Cash Flow data on file, last reported at -$6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 411.53% year-over-year to -$6.2 million; the trailing twelve-month figure through Mar 2026 stood at -$5.2 million (down 50.09% YoY), and the FY2025 full-year result was $3.0 million, up 141.66% from the prior year.
• Net Cash Flow declined to -$6.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $14.7 million in Q2 2024 to a low of -$115.9 million in Q1 2022.
• A 5-year average of -$9.7 million and a median of -$1.9 million in 2024 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 243.98% in 2024, while the deepest fall reached 1112.42% in 2024.
• Tracing RPID's Net Cash Flow over 5 years: stood at $1.2 million in 2022, then slumped by 59.5% to $499000.0 in 2023, then tumbled by 1112.42% to -$5.1 million in 2024, then jumped by 121.46% to $1.1 million in 2025, then slumped by 673.34% to -$6.2 million in 2026.
• Business Quant data shows RPID's Net Cash Flow at -$6.2 million in Q1 2026, $1.1 million in Q4 2025, and $613000.0 in Q3 2025.